Is the Debate on the Flecainide Action on the RYR2 in CPVT Closed?
Sign Up to like & getrecommendations! Published in 2021 at "Circulation Research"
DOI: 10.1161/circresaha.121.318706
Abstract: The class IC antiarrhythmic agent flecainide, developed in the 70s as a more stable local anesthetic by incorporating of fluorine, is nowadays recommended as one of the first-line rhythm control therapeutic options in patients without… read more here.
Keywords: ryr2 cpvt; ryr2; action; flecainide ... See more keywords